Medications
Compounded Semaglutide, Compounded Tirzepatide, Ozempic, Wegovy, Zepbound
Monthly Cost
$149/mo semaglutide; $224/mo tirzepatide
Speed to Start
Fast
Est. 2021
About Ivim Health
Ivim Health is the highest-scoring provider in our directory, and it earns that distinction through a combination of clinical excellence, transparency, and patient satisfaction that few competitors can match. Founded in 2021, the platform has rapidly scaled while maintaining the kind of quality markers — published clinical research, CoA testing, lab work, and dietitian access — that define best-in-class GLP-1 care.
Ivim offers both compounded semaglutide ($149/month) and compounded tirzepatide ($224/month), plus brand-name options like Ozempic, Wegovy, and Zepbound for patients who prefer FDA-approved formulations. Insurance is accepted alongside self-pay, making it accessible across different financial situations.
The clinical program is comprehensive. Every patient gets lab testing included, access to a registered dietitian, and ongoing medical support from providers who follow evidence-based protocols. Ivim has also published clinical research on their approach — a level of scientific transparency that’s virtually unheard of among telehealth GLP-1 providers.
Patient satisfaction metrics are exceptional: a 4.9 Trustpilot rating across 36,000+ reviews combined with an A+ BBB rating. That combination of volume, rating quality, and institutional trust is the strongest in our database by a significant margin.
Ivim provides a Certificate of Analysis for their compounded medications and maintains high trust and compliance transparency throughout their platform. The holistic approach — combining medication, lab monitoring, nutritional guidance, and ongoing clinical support — reflects the kind of integrated care model that produces the best long-term outcomes.
Ivim Health GLP-1 Medications
At a Glance
Medications Offered
Compounded Semaglutide, Compounded Tirzepatide, Ozempic, Wegovy, Zepbound
Both
Cost & Insurance
- Monthly: $149/mo semaglutide; $224/mo tirzepatide
- 6-month estimate: $600 semaglutide / $1,100 tirzepatide (promo pricing shown)
- Insurance: Yes
- Self-pay: Yes
Clinical Features
- Lab testing: Yes
- Dietitian access: Yes
- Verified Pharmacy: FDA-inspected, state-regulated 503A/503B compounding pharmacies; specific partners not publicly named; CoA provided
- BBB Rating: A+
Delivery & Access
- Format: Both
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not available
Start your GLP-1 weight loss journey with Ivim Health today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
What the Ivim Intake Looks Like
We walked through Ivim Health’s intake ourselves. This walkthrough was interrupted partway through by a loading error — so the observations below cover everything we saw before the error, but there may be additional clinical questions after the account-setup step that we weren’t able to observe.
/ 10
Based on the pre-error portion of the flow. The observable questions cover goal, timeline, GLP-1 history, and BMI — the deeper clinical screens may sit on the other side of the account-setup step.
/ 10
High. The intake requires a 6-digit phone OTP, collects a full mailing address mid-flow, captures email behind a “free first month” promo, and requires a password before the clinical questions begin.
The 8 Stages Observed
Immediately after the password-setup step, the intake returned an “error loading your information” message and the flow could not be continued. That means the observations above may represent only the first half of Ivim’s full intake — a deeper clinical questionnaire may sit behind the account-setup step that we were unable to observe. When we next walk through Ivim’s flow successfully, we will update this section with any additional screens found.
Ivim recommends compounded tirzepatide as its “expert recommendation” by screen 6 of the flow — before collecting any comorbidity history, medication list, allergy information, or family history, and before any clinician has reviewed the patient’s profile. The recommendation appears to be a product of the goal, timeline, and GLP-1 history answers alone. For patients this is a fast preview of what they’re likely to be prescribed; for readers evaluating clinical rigor it’s a flag worth being aware of.
Source: GLP-1.Reviews editorial walkthrough on April 13, 2026. Walkthrough was interrupted by a technical error after the password step. We stopped before submitting any payment information.
Opens ivimhealth.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
